SI
SI
discoversearch

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor.  We ask that you disable ad blocking while on Silicon Investor in the best interests of our community.  If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.
Biotech / Medical : IDPH--Positive preliminary results for pivotal trial of ID
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  
To: Roudy who wrote (154)12/3/1996 4:43:00 PM
From: I. Luttichuys   of 1762
 
Hello Don, I was excited to see your post and to be able to take advantage of the opportunity you present. As we are all on the thread already aware, there are many aspects to IDEC's therapies which make them unique both to the comfort and well-being of the patient which may undergo them and to the institution which may implement them in these cost-conscious times. I will send an e-mail this evening in which I will cover what I think some of these unique aspects are.
Publicity for these therapies is more than over-due. After this, a patient will have 60% or greater chance at remission without having to "fear the treatment almost as much as the disease". With respect to CE9.1, a patient will have a chance at actually having the course of their disease ALTERED, that is to say not merely hidden. The deformation which ultimately comes from rheumatoid arthritis can not be prevented in any other way. These are indeed, as we have said here many times before, exciting new therapies which I think will bode well for patients and for the company and the coming years.
Anyway, I appreciate your thanks and I of course thank you for your input and for starting this thread. I continue to learn a great deal here.

Have a good evening,
BENNETT
Report TOU ViolationShare This Post
 Public ReplyPrvt ReplyMark as Last ReadFilePrevious 10Next 10PreviousNext  

HomeMailHotSubjectMarksPeopleMarksKeepersSettings
Terms Of UseContact UsCopyright/IP PolicyPrivacy PolicyAbout UsFAQAdvertise on SI
© 2025 Knight Sac Media.  Data provided by Twelve Data, Alpha Vantage, and CityFALCON News